Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methotrexate Iontophoresis Versus Methotrexate 1% Gel on Depigmentation in Vitiligo Patients

NCT07208890 is registered in ClinicalTrials.gov with Pharos University in Alexandria as lead sponsor.

NCT NCT07208890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07208890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methotrexate Iontophoresis Versus Methotrexate 1% Gel on Depigmentation in Vitiligo Patients
Lead sponsor
Pharos University in Alexandria
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 10, 2025
Completion date
March 10, 2026
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo - evaluation of methotrexate iontophoresis and topical methotrexate gel as localized treatment approache